Antithrombotic treatment in patients with unstable coronary artery disease undergoing CABG.
Stahle
E
E
Lindahl
B
B
D000789:Angina, Unstable / Q000601:surgery*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D017985:Dalteparin / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D012306:Risk
D005343:Fibrinolytic Agents; D017985:Dalteparin